Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-06 4:18 pm Sale |
2025-02-28 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
MORGAN STANLEY MS |
0 0.000% |
-3,298,215![]() (Position Closed) |
Filing History |
2025-02-14 4:30 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Panacea Venture Healthcare Fund II, L.P. | 0 0.000% |
-5,500,000![]() (Position Closed) |
Filing History |
2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
TANG CAPITAL PARTNERS LP | 1,641,945 3.000% |
-2,860,912![]() (-63.54%) |
Filing History |
2025-02-12 6:40 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Sofinnova Investments Inc. | 0 0.000% |
-4,386,177![]() (Position Closed) |
Filing History |
2025-02-11 8:45 pm Purchase |
2025-02-07 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,022,612 5.500% |
917,348![]() (+43.57%) |
Filing History |
2025-02-11 8:20 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,105,264 3.800% |
-3,358,377![]() (-61.47%) |
Filing History |
2025-02-11 11:08 am Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-4,713,014![]() (Position Closed) |
Filing History |
2025-02-04 2:13 pm Purchase |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
MORGAN STANLEY MS |
3,298,215 6.000% |
3,298,215![]() (New Position) |
Filing History |
2025-01-31 12:14 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,596,768 4.700% |
-206,197![]() (-7.36%) |
Filing History |
2025-01-07 7:15 pm Purchase |
2024-12-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Beryl Capital Management LLC | 5,462,942 9.900% |
5,462,942![]() (New Position) |
Filing History |
2024-11-15 10:35 am Sale |
2024-11-14 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
PRUDENTIAL FINANCIAL INC PRU |
385,250 0.700% |
-2,924,741![]() (-88.36%) |
Filing History |
2024-11-14 6:39 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Sofinnova Investments Inc. | 4,386,177 8.000% |
4,386,177![]() (New Position) |
Filing History |
2024-11-14 3:04 pm Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Cormorant Asset Management LP | 0 0.000% |
-3,250,000![]() (Position Closed) |
Filing History |
2024-11-14 12:24 pm Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 0 0.000% |
-4,529,997![]() (Position Closed) |
Filing History |
2024-11-14 09:34 am Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-3,150,000![]() (Position Closed) |
Filing History |
2024-11-12 4:01 pm Unchanged |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,802,965 5.080% |
0 (Unchanged) |
Filing History |
2024-11-12 09:55 am Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
JENNISON ASSOCIATES LLC | 0 0.000% |
-2,959,161![]() (Position Closed) |
Filing History |
2024-11-04 1:43 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
The Vanguard Group | 2,802,965 5.080% |
2,802,965![]() (New Position) |
Filing History |
2024-11-01 8:30 pm Purchase |
2024-10-25 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Panacea Venture Healthcare Fund II, L.P. | 5,500,000 9.980% |
5,500,000![]() (New Position) |
Filing History |
2024-10-31 1:05 pm Purchase |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
FRANKLIN RESOURCES INC BEN |
4,713,014 8.600% |
879,059![]() (+22.93%) |
Filing History |